ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q2Scopus Q2SCImago #5,711Hybrid

Rheumatology International

Acronym:rhei
•
Abbreviation (ISO):RHEUMATOL INT
•
Identifier (ISSN):0172-8172(Print)/1437-160X(Online)
•
Publisher:Springer Berlin Heidelberg
Clarivate IF (2026)
3.5↑ +0.6
Journal Impact Factor
IF Trend↓
WoS Quartile
Q2
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Rheumatology International

WoS Q2
13461.9520182.220191.9820202.6320213.582022420233.220242.920253.52026
Annual Impact Factor Metric
Current (2026):3.5
Scopus SJR & RankScopus Q2
0.907
#5,711

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
100

100 papers with at least that number of citations each

WoS: SCIE / JCRQ2
Self-Citation Rate6.2%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
280articles/year
42.7% Gold OA•67.69% Original Research

Aims & Scope

RHEUMATOLOGY INTERNATIONAL is an independent journal reflecting world-wide progress in the research, diagnosis and treatment of the various rheumatic diseases. It is designed to serve researchers and clinicians in the field of rheumatology. RHEUMATOLOGY INTERNATIONAL will cover all modern trends in clinical research as well as in the management of rheumatic diseases. Special emphasis will be given to public health issues related to rheumatic diseases, applying rheumatology research to clinical practice, epidemiology of rheumatic diseases, diagnostic tests for rheumatic diseases, patient reported outcomes (PROs) in rheumatology and evidence on education of rheumatology. Contributions to these topics will appear in the form of original publications, short communications, editorials, and reviews. "Letters to the editor" will be welcome as an enhancement to discussion. Basic science research, including in vitro or animal studies, is discouraged to submit, as we will only review studies on humans with an epidemological or clinical perspective. Case reports without a proper review of the literatura (Case-based Reviews) will not be published. Every effort will be made to ensure speed of publication while maintaining a high standard of contents and production. Manuscripts submitted for publication must contain a statement to the effect that all human studies have been reviewed by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in an appropriate version of the 1964 Declaration of Helsinki. It should also be stated clearly in the text that all persons gave their informed consent prior to their inclusion in the study. Details that might disclose the identity of the subjects under study should be omitted.

Topics Covered (Recognized by AI)
MedicineInternal MedicineBiologyPsychologyPathologyPsychiatryRadiologyImmunologySurgeryGeneticsPathology & DiseasesChemistryBiochemistryEndocrinologyGastroenterologyMathematicsPhysical Therapy
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

RHEUMATOLOGY

Q2
Rank18/58
IndexSCIE
JCISCIE2026

RHEUMATOLOGY

Q2
Rank22/58
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF3.5
Articles / Year236
Total Citations103
2025
IF2.9
Articles / Year294
Total Citations1,046
2024
IF3.2
Articles / Year247
Total Citations1,764
2023
IF4
Articles / Year249
Total Citations2,587
2022
IF3.58
Articles / Year202
Total Citations2,825

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #5,711Scopus Q2SCImago Profile
Scopus Coverage:1981-2026
Scopus Broad Areas:Immunology and MicrobiologyMedicine
Scopus Citation Rank (SJR)Q2
0.907

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2
Citations / Doc (2 years)
3.31

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,282 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations2,573
3-Year Documents796
Citable Documents766

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate49.8%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

ImmunologyQ2
Immunology and AllergyQ2
RheumatologyQ2
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 6.2%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
3区RHEUMATOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Rheumatology International (acronym: rhei, abbr: RHEUMATOL INT, ISSN: 0172-8172) is a peer-reviewed international scholarly journal in the field of Medicine, published by Springer Berlin Heidelberg in Germany since 1981. The periodical holds a Journal Impact Factor (JIF) of 3.50, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 0.907 (Q2), an H-index of 100.

The journal enforces rigorous peer evaluation with a publication frequency of Tri-annual, an annual output of approximately 280 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,282 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Springer Berlin Heidelberg
Publication Language
English
Frequency
Tri-annual
Founding Year
1981
Indexing & Databases
SCIEScopusPubMed
Editorial Address
SPRINGER, 233 SPRING ST, NEW YORK, USA, NY, 10013

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 1efe1782-dab0-409f-84d7-78c074a7ee9e
Database Updated: 2026-09-28